Stock comparison
BRUKER CORP is 7.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($9.14 B vs $1.23 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BRKR is larger
BRUKER CORP is 7.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($9.14 B vs $1.23 B).
Market value leader
BRKR
BRUKER CORP is 7.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($9.14 B vs $1.23 B).
Revenue leader
BRKR
EYPT: $31.37M vs BRKR: $3.44B.
Profit leader
BRKR
EYPT: -$231.96M vs BRKR: -$8.30M.
Margin leader
BRKR
EYPT: -739.4% vs BRKR: -0.2% net margin.
| Metric | EYPT | BRKR |
|---|---|---|
| Market cap | $1.23 B | $9.14 B |
| US-listed rank | #2501 | #1006 |
| Revenue (latest FY) | $31.37M | $3.44B |
| Net income (latest FY) | -$231.96M | -$8.30M |
| Net margin | -739.4% | -0.2% |
| P/E (trailing FY) | - | - |
| SEC filings | 1,308 | 1,361 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BRUKER CORP is 7.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($9.14 B vs $1.23 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while BRUKER CORP reported $3.44B.
Full pages: EyePoint Pharmaceuticals, Inc. and BRUKER CORP, or browse the full rankings.